Paper36927491
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.
Gonzalez-Ortiz F and 5 others. Mol Neurodegener, 2023. Cited by 189 papers, by iCite.
Cite this record
ConductScience Library. Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications. Papers, record 36927491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36927491
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cognitive Dysfunction | Major topic |
| Humans | |
| tau Proteins | |
| Biomarkers | |
| Neuropathology | |
| Amyloid beta-Peptides |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35618838 | Performance of plasma phosphorylated tau 181 and 217 in the community. | Nat Med | 2022 | https://conductscience.org/library/papers/35618838 | PubMed |
| 2 | 36251300 | Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial. | JAMA Neurol | 2022 | https://conductscience.org/library/papers/36251300 | PubMed |
| 3 | 34998485 | Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. | Lancet Public Health | 2022 | https://conductscience.org/library/papers/34998485 | PubMed |
| 4 | 23399646 | Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. | Nat Rev Neurol | 2013 | https://conductscience.org/library/papers/23399646 | PubMed |
| 5 | 36456833 | Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring. | Nat Med | 2022 | https://conductscience.org/library/papers/36456833 | PubMed |
| 6 | 27371494 | A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. | Neurology | 2016 | https://conductscience.org/library/papers/27371494 | PubMed |
| 7 | 28592453 | Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. | Neurology | 2017 | https://conductscience.org/library/papers/28592453 | PubMed |
| 8 | 33585983 | Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology. | Acta Neuropathol | 2021 | https://conductscience.org/library/papers/33585983 | PubMed |
| 9 | 29653606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 10 | 32725127 | Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. | J Exp Med | 2020 | https://conductscience.org/library/papers/32725127 | PubMed |
| 11 | 34494715 | Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease. | Alzheimers Dement | 2022 | https://conductscience.org/library/papers/34494715 | PubMed |
| 12 | 33252199 | Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis. | Alzheimers Dement | 2021 | https://conductscience.org/library/papers/33252199 | PubMed |
| 13 | 16488378 | Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. | Lancet Neurol | 2006 | https://conductscience.org/library/papers/16488378 | PubMed |
| 14 | 27068280 | CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27068280 | PubMed |
| 15 | 22487856 | Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. | J Neuropathol Exp Neurol | 2012 | https://conductscience.org/library/papers/22487856 | PubMed |
| 16 | 1759558 | Neuropathological stageing of Alzheimer-related changes. | Acta Neuropathol | 1991 | https://conductscience.org/library/papers/1759558 | PubMed |
| 17 | 32722745 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2020 | https://conductscience.org/library/papers/32722745 | PubMed |
| 18 | 24231570 | Cerebrospinal fluid biomarkers in cardiac arrest survivors. | Resuscitation | 2014 | https://conductscience.org/library/papers/24231570 | PubMed |
| 19 | 33283854 | CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. | Brain | 2021 | https://conductscience.org/library/papers/33283854 | PubMed |
| 20 | 31129184 | Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid. | Clin Biochem | 2019 | https://conductscience.org/library/papers/31129184 | PubMed |
Cited by145
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948835 | Blood-Based Biomarkers in Alzheimer's Disease: Advances in Detection Technologies and Clinical Applications. | Aging Med (Milton) | 2026 | https://conductscience.org/library/papers/42948835 | PubMed |
| 42926809 | Plasma eMTBR-tau as a robust biomarker for Alzheimer's disease tangle pathology up to 10 years before death. | medRxiv | 2026 | https://conductscience.org/library/papers/42926809 | PubMed |
| 42795418 | Comparative Analysis of Plasma Biomarkers of Alzheimer's Disease and Frontotemporal Dementia: The Dual Role of Soluble Fractalkine as a Biomarker of Frontotemporal Dementia and Its Neuroprotective Effects in Cortical Neurons "In Vitro". | Life (Basel) | 2026 | https://conductscience.org/library/papers/42795418 | PubMed |
| 42670516 | Circulating pTau181 and Genomic Background in Dogs: A Pilot Study on Neurobiological Aging. | Vet Med Int | 2026 | https://conductscience.org/library/papers/42670516 | PubMed |
| 42631717 | Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/42631717 | PubMed |
| 42585316 | Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers. | Sci Adv | 2026 | https://conductscience.org/library/papers/42585316 | PubMed |
| 42463545 | Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42463545 | PubMed |
| 42437975 | Proteomics of post mortem brains in early- and late-onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42437975 | PubMed |
| 42422561 | Brain age gradients as intermediate phenotypes linking plasma p-tau217 to cognition in community-dwelling older adults. | NPJ Dement | 2026 | https://conductscience.org/library/papers/42422561 | PubMed |
| 42415930 | Peripheral metabolomic profiling reveals lipid and amino acid alterations associated with immuno-inflammatory responses in treatment-naïve late-onset Alzheimer's disease. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42415930 | PubMed |
| 42396306 | Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two Cohorts. | medRxiv | 2026 | https://conductscience.org/library/papers/42396306 | PubMed |
| 42368190 | Atypical involvement of Alzheimer's tau proteins in diseases beyond tauopathies. | Life Med | 2026 | https://conductscience.org/library/papers/42368190 | PubMed |
| 42340485 | Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42340485 | PubMed |
| 42325435 | The gut-brain axis in Alzheimer's disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42325435 | PubMed |
| 42273887 | Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42273887 | PubMed |
| 42251493 | Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42251493 | PubMed |
| 42238423 | CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progression. | medRxiv | 2026 | https://conductscience.org/library/papers/42238423 | PubMed |
| 42171824 | β-Asarone, Tenuifolin, and YuanZhi Decoction Restore Cognitive Function and Modulate GRIN2B-Associated Autophagy in Alzheimer's Disease. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42171824 | PubMed |
| 42164127 | Integrating neuroimaging and plasma biomarkers to predict preclinical Alzheimer's disease progression. | Front Neurol | 2026 | https://conductscience.org/library/papers/42164127 | PubMed |
| 42004319 | Heme-mediated Tau phosphorylation drives neurocognitive responses in sickle cell disease. | Blood Red Cells Iron | 2026 | https://conductscience.org/library/papers/42004319 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| NEFL | 4747 | PubTator's text mining | https://conductscience.org/library/genes/4747 | NCBI Gene |
| PLK3 | 1263 | PubTator's text mining | https://conductscience.org/library/genes/1263 | NCBI Gene |
| PSEN1 | 5663 | PubTator's text mining | https://conductscience.org/library/genes/5663 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36927491
GET https://conductscience.org/api/papers/v1/36927491/references?page=2